ENCODED THERAPEUTICS

Encoded Therapeutics

Gene Therapy · South San Francisco, California · United States · Founded · 2019 · ≈ · 80 · employees

Encoded Therapeutics competitors

Company

Encoded Therapeutics has 4 close competitors: Alloy Therapeutics, Biosplice Therapeutics, Formation Bio.

Head-to-head

Encoded Therapeutics and its peers, side by side

A private valuation and a public market cap share one column; each row names its basis and date.

Company

Sector

Founded

Valuation / market cap

Status

HQ

On Canborsa

ETEncoded Therapeutics

Gene Therapy

2019

no figure

United States

Company profile

ATAlloy Therapeutics

Biotech

2011

$1B

PRIVATE

United States

Company profile

Biosplice Therapeutics

Biopharmaceutical — regenerative medicine / alternative pre-mRNA splicing therapeutics

2008

$12BApr 2021

PRIVATE

United States

Company profile

Formation Bio

Biotechnology / Drug discovery

2016

$1.7BJun 2024

PRIVATE

United States

Company profile

Lila Sciences

Biotechnology / AI

2025

$8.5Bpre-money · Jun 2026

PRIVATE

United States

Company profile

Context · reading the peer set

Biopharmaceutical company focused on genetic medicine and therapeutics

Encoded Therapeutics competes with 4 companies here: Alloy Therapeutics, Biosplice Therapeutics, Formation Bio, Lila Sciences.

Encoded Therapeutics on Canborsa

MarketClosest: SP500-PERP

Fees0.07% per side · 0.14% round-trip

Fundingevery 1h

Who are Encoded Therapeutics's competitors?›

The closest gene therapy peers are on the competitors page.

How can I get exposure to Encoded Therapeutics?›

The routes section explains what is realistically available for a company at this stage.

Is Encoded Therapeutics publicly traded?›

No. Encoded Therapeutics is a private company; its shares do not trade on a public exchange.

Who has invested in Encoded Therapeutics?›

Lead investors for each round are in the funding timeline.

Index · Perpetual · 30x

S&P 500 · the Canborsa market closest to Encoded Therapeutics